CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Done›
Analysis
Done

Done

Done operates a telehealth platform connecting patients with clinicians for ADHD assessment, treatment planning, and continuing psychiatric care.

Operating headquarters
San Francisco, CA, US🇺🇸
Founded
2019
Loading
Overview
Analysis
Compare
Employees
News
Library

Contents

  1. 01Executive Summary
  2. 02Products & Services
  3. 03Competitive Strengths
  4. 04Competitive Risks
  1. 01Executive Summary
  2. 02Products & Services
  3. 03Competitive Strengths
  4. 04Competitive Risks

Memo

On June 13, 2024, the Justice Department announced charges against Done Global founder Ruthia He and Done Health clinical president David Brody over alleged unlawful stimulant distribution and health-care fraud. Those charges were allegations when announced. In its November 19, 2025 release, DOJ reported that a jury convicted both defendants of controlled-substance conspiracy, four distribution counts, and health-care-fraud conspiracy; He was also convicted of obstruction conspiracy.

These individual convictions are a material regulatory risk for a platform centered on ADHD care and prescription coordination, without establishing that every current clinician or prescription is unlawful. Done's terms identify Done Global as a technology operator and independent medical groups as care providers. The federal history therefore belongs alongside, and separately from, the current service description, with allegations and adjudicated outcomes distinguished by date.

Source: justice.gov

Product Overview

Done provides an online ADHD care pathway that connects patients with clinicians for assessment, diagnosis, treatment planning, therapy, coaching, medication decisions, and continuing follow-up. Its public pages also describe care-team support and pharmacy delivery or pickup coordination.

Service access, prescriptions, and pharmacy fulfillment depend on clinical judgment, state rules, and patient location. The current public offering is centered on ADHD care, with anxiety, depression, and insomnia discussed as related mental-health concerns.

Source: donefirst.com

Competitive Advantages

Done’s official pages emphasize a focused ADHD pathway with online assessment, clinician appointments, continuing care, prescription renewals, care-team support, and pharmacy coordination. The platform presents these steps in one patient-facing membership flow.

Its current treatment page also distinguishes medication, therapy, coaching, and CBT as possible parts of care. The service makes the clinical decision with a licensed provider rather than promising a prescription for every patient.

Source: donefirst.com

Competitive Disadvantages

Done's care pathway concentrates on ADHD assessment, psychiatric treatment, follow-up, and prescription coordination. Its official pages make treatment dependent on clinical decisions and pharmacy availability, exposing the service to controlled-substance rules and interruptions in medication access.

The Justice Department's November 19, 2025 announcement reports convictions of Ruthia He and David Brody for controlled-substance distribution and health-care-fraud conspiracy, with an additional obstruction-conspiracy conviction for He. This dated legal history creates material regulatory risk and warrants evaluation separately from current service availability.

Source: justice.gov